# 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

> **NCT04483414** · PHASE2 · WITHDRAWN · sponsor: **Dana Mathews**

## Conditions studied

- Prostate Cancer
- Prostate Cancer Metastatic
- Prostate Cancer Metastatic to Bone

## Interventions

- **DRUG:** 68Ga PSMA-11 injection
- **PROCEDURE:** Positron Emission Tomography/Computed Tomography

## Key facts

- **NCT ID:** NCT04483414
- **Lead sponsor:** Dana Mathews
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-19
- **Primary completion:** 2023-04-05
- **Final completion:** 2023-04-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was closed since no participants were enrolled.
- **Last updated:** 2023-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04483414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04483414, "68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04483414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*